The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Modern use of clomiphene citrate in induction of ovulation
Abstract
Clomiphene citrate is the treatment of first choice in the management of infertility in normally oestrogenized, anovulatory women (WHO group II). The majority of women with 'pure' anovulatory infertility respond to treatment with clomiphene citrate. The rates of pregnancy and miscarriage are close to those expected in a normal fertile population. Basal hormone concentrations do not predict outcome. An increased body mass index is the only factor which is consistently associated with a decreased response to clomiphene citrate; it follows therefore, that weight reduction should be an important part of therapy in anovulatory women. According to our data, only an increased luteinizing hormone value immediately post clomiphene citrate predicted an adverse pregnancy outcome in women who conceived. Clomiphene citrate, along with other ovulation induction therapies, can cause multiple follicular development, with a risk of ovarian hyperstimulation and multiple pregnancy. Ultrasound monitoring of treatment is important in order to choose the appropriate dose of clomiphene citrate in subsequent cycles and to minimize the risks of hyperstimulation and multiple pregnancy. When couples with other factors contributing to subfertility are excluded, the cumulative conception rate continues to rise after 6 months of treatment with clomiphene citrate, reaches a plateau by treatment cycle 12 and approaches that of the normal population. It has been reported that prolonged use of clomiphene citrate may be associated with an increased risk of a borderline or invasive ovarian tumour. Taking into consideration these observations, we recommend that anovulatory women responsive to clomiphene citrate should be treated for at least 6 cycles before considering more complex or invasive methods of ovulation induction, and that treatment should probably be limited to a maximum of 12 cycles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Population study of causes, treatment, and outcome of infertility.
Hull, M. G., Glazener, C. M., Kelly, N. J., Conway, D. I., Foster, P. A., Hinton, R. A., Coulson, C., Lambert, P. A., Watt, E. M., & Desai, K. M. (1985) · BMJ · doi:10.1136/bmj.291.6510.1693 · Cited by 1,141
Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.
Adams, J., Polson, D. W., & Franks, S. (1986) · BMJ · doi:10.1136/bmj.293.6543.355 · Cited by 981
Ovarian Tumors in a Cohort of Infertile Women
Rossing, M. A., Daling, J. R., Weiss, N. S., Moore, D. E., & Self, S. G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311204 · Cited by 721
Hypersecretion of luteinising hormone, infertility, and miscarriage
Regan, L., Owen, E. J., & Jacobs, H. S. (1990) · The Lancet · doi:10.1016/0140-6736(90)92765-a · Cited by 450
Homburg, R., Armar, N. A., Eshel, A., Adams, J., & Jacobs, H. S. (1988) · BMJ · doi:10.1136/bmj.297.6655.1024 · Cited by 436
RESHEF, E., LEI, Z. M., RAO, C. V., PRIDHAM, D. D., CHEGINI, N., & LUBORSKY, J. L. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-2-421 · Cited by 353
Recurrent early miscarriage and polycystic ovaries.
Sagle, M., Bishop, K., Ridley, N., Alexander, F. M., Michel, M., Bonney, R. C., Beard, R. W., & Franks, S. (1988) · BMJ · doi:10.1136/bmj.297.6655.1027 · Cited by 283
Gysler, M., March, C. M., Mishell, D. R., & Bailey, E. J. (1982) · Fertility and Sterility · doi:10.1016/s0015-0282(16)46033-4 · Cited by 270
Clomiphene citrate: mechanism(s) and site(s) of action—a hypothesis revisited
Wallach, E. E., & Adashi, E. Y. (1984) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48069-6 · Cited by 249
White, D. M. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.11.3821 · Cited by 249
Cited by
Estrogen–gut microbiome axis: Physiological and clinical implications
Baker, J. M., Al-Nakkash, L., & Herbst-Kralovetz, M. M. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.06.025 · Cited by 993
Metformin in polycystic ovary syndrome: systematic review and meta-analysis
Lord, J. M., Flight, I. H. K., & Norman, R. J. (2003) · BMJ · doi:10.1136/bmj.327.7421.951 · Cited by 786
Consensus on infertility treatment related to polycystic ovary syndrome
(2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.09.041 · Cited by 730
Balen, A. H., Morley, L. C., Misso, M., Franks, S., Legro, R. S., Wijeyaratne, C. N., Stener-Victorin, E., Fauser, B. C. J. M., Norman, R. J., & Teede, H. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw025 · Cited by 705
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Franks, S., Gambineri, A., Kelestimur, F., Macut, D., Micic, D., Pasquali, R., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0253 · Cited by 676
Metadata
- Authors
- Kousta, E.
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-07-01
- Volume
- 3
- Issue
- 4
- Pages
- 359-365
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2106543279
- Cited by
- 333
- References
- 26
- FWCI
- 6.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modern use of clomiphene citrate in induction of ovulation. https://app.cochat.ai/papers/10.1093/humupd/3.4.359
- The paper
- Kousta, E. (1997). Modern use of clomiphene citrate in induction of ovulation. Human Reproduction Update. https://doi.org/10.1093/humupd/3.4.359
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.